Participation in faecal occult blood screening for colorectal cancer in a well defined French population: Results of five screening rounds from 1988 to 1996

Journal of Medical Screening

Volumn 4, Issue 3, 1997, Pages 147-151

  Tazi, M A ^a   Faivre, J ^a   Dassonville, F ^a   Lamour, J ^a   Milan, C ^a   Durand, G ^a  

^a INSERM   (France)

Author keywords

Colorectal cancer; Compliance; Faecal occult blood test

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FRANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PATIENT COMPLIANCE;

EID: 0031399732     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1177/096914139700400307     Document Type: Article

References (22)

1. Eddy DM. Secondary prevention of cancer: an overview. Bull World Heahh Organ 1986;64:421-9.
2. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med 1991;325:37-11.
3. Young GP, Macrae FA, St John DJ. Clinical methods for early detection: basic use and evaluation. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: Saunders, 1996:241-70.
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for faecal occult blood. N Engl J Med 1993;328:1365-71.
5. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal occult blood test. Lancet 1996;348:1467-71.
6. Kewenter J, Brevence H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by faecal occult blood testing. Results of 68,308 subjects. Scand J Gastroenterol 1994;29:468-73.
7. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer. Lancet 1996;348:1472-7.
8. Herbert C, Launoy G, Thezee Y, et al. Participants' characteristics in a French colorectal cancer mass screening campaign. Prev Med 1995;24:498-502.
9. Dent OF, Bartrop R, Goulston KJ, Chapuis PH. Participation in faecal occult blood screening for colorectal cancer. Soc Sci Med 1983;17:17-23.
10. Silman A, Mitchell P. Attitudes of non-participants in an occupational based programme of screening for colorectal cancer. Community Medicine 1984;6:8-11.
11. Farrands PA, Hardcastle JD. Factors affecting compliance with screening for colorectal cancer. Community Medicine 1984;6:12-19.
12. Klaaborg K, Madsen MS, Sondergaard O, Kronborg O. Participation in mass screening for colorectal cancer with faecal occult blood test. Scand J Gastroemerol 1986;21: 1180-4.
13. Lecomte T, Mizrahi AN, Mizrahi AR. Presentation de l'enquête nationale 1980-1981 sur les consommations médicales. Paris: CREDES, 1980.
14. Dubois G, Petit J, Marty J. Evaluation médicale de l'action de prévention du cancer colorectal par la recherche de sang dans les selles à l'aide du test Hemoccult®. Revue Médicale de l'Assurance Maladie 1988;4:13-18.
15. Dupon C, Thielly P, Allemand H. Les médecins conseils et les agents du Service Médicale et l'Assurance Maladie de la région Aquitaine. Revue Médicale de l'Assurance Maladie 1993;2:101-7.
16. Lallemand RC, Vakil PA, Pearson P, Box V. Screening for asymptomatic bowel cancer in general practice. BMJ 1984; 288:31-3.
17. Nichols S, Koch E, Lallemang RC, et al. Randomised trial of compliance with screening for colorectal cancer. BMJ 1986;293:107-10.
18. Launoy G, Herbert C, Vallee JP, et al. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165 000 personnes dans le Calvados. Gastroenterol Clin Biol 1996;20:228-36.
19. Hobbs FDR, Cherry RC, Fielding JWL, Pike L, Holder R. Acceptability of opportunistic screening for occult gastrointestinal blood loss. BMJ 1992;304:483-6.
20. Hardcastle JD, Ferrands PA, Balfour TW, et al. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet 1983;2:1-4.
21. Pey G, Christie M, Chamberlain JO, Moss SM, Hardcastle JD. A comparison of methods for increasing compliance within a general practioner-based screening project for colorectal cancer and the effect on a practioner's workload. J Epidemiol Community Health
22. Arveux P, Durand G, Milan C, et al. Views of a general population on mass screening for colorectal cancer: the Burgundy study. Prev Med 1992;21:574-81.